I have just one question. Considering the challenging environment for the pharma sector in the U.S. and whatever we have witnessed in past 1 year, can you share some qualitative insight, the type of conversations, which are ongoing with the client and the type of solutions, which they are asking and which they were asking a year back or 2 years back? Any change in the behavior in this client pattern or if you share some qualitative insight that would be useful.
Questions across 1 call
Chirag Kachhadiya
Motilal Oswal Financial Services Limited